4 The aim of the study was to test nivolumab/ipilimumab compared with either sorafenib or lenvatinib ... were randomly assigned to either receive 1-mg/kg nivolumab plus 3-mg/kg ipilimumab with ...

The approval is based on the results from the CheckMate-9DW trial, in which 85% of patients in the comparator arm were treated with lenvatinib and 15% were treated with sorafenib monotherapy.

FDA Approves Combo of Opdivo Plus Yervoy for Advanced Liver Cancer By Lori Solomon HealthDay Reporter TUESDAY, April 15, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved ...